Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Expected Growth Rate of the Candidiasis Therapeutics Market from 2024 to 2033?

The candidiasis therapeutics market has grown steadily, increasing from $3.06 billion in 2023 to $3.19 billion in 2024 at a 4.4% CAGR, fueled by higher incidence rates, antibiotic resistance, hospital-acquired infections, changes in fungal resistance, and awareness efforts.

The candidiasis therapeutics market is projected to grow steadily, reaching $3.66 billion by 2028, at a CAGR of 3.5%. This growth is driven by precision medicine, global antifungal stewardship programs, increasing cases of Candida auris, and global efforts against antifungal resistance. Key trends include advancements in drug delivery technologies, telemedicine and remote monitoring, patient-centric care, combination therapies, and collaborative research.

Claim Your Free Sample of the Global Candidiasis Therapeutics Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=13182&type=smp

What Key Factors Are Fueling the Growth of the Candidiasis Therapeutics Market?

The rising incidence of fungal infections is expected to accelerate the candidiasis therapeutics market. Fungal infections, particularly among individuals with weakened immune systems, are driving the demand for specialized antifungal treatments targeting Candida infections. In July 2023, the Centers for Disease Control and Prevention reported that fungal infection-related hospitalizations reached 59,212 in 2021, with an 8.5% annual increase. The increasing prevalence of fungal infections supports the growth of the candidiasis therapeutics market.

What Are the Major Segments of the Candidiasis Therapeutics Market?

1) By Treatment Type: Medication, Surgery, Other Treatments

2) By Anatomy Type: Oral Candidiasis, Vulvovaginal Candidiasis, Cutaneous Candidiasis, Invasive Candidiasis, Systemic Candidiasis

3) By Mode of Administration: Injectable, Oral, Other Mode of Administrations

4) By Patient Population: Adults, Pediatrics

5) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

What New Trends Are Transforming the Candidiasis Therapeutics Market?

Companies in the candidiasis therapeutics market are focusing on drugs like BREXAFEMME (ibrexafungerp tablets) to address recurrent vulvovaginal candidiasis (RVVC) in women. In December 2022, Scynexis Inc. received FDA approval for BREXAFEMME, an oral medication that prevents chronic yeast infections by inhibiting Candida albicans. The treatment involves one 150-mg capsule daily for a single day.

Order Now for Fast Delivery of Your Candidiasis Therapeutics Market Report!

https://www.thebusinessresearchcompany.com/report/candidiasis-therapeutics-global-market-report

Which Regions Are Driving Growth in the Candidiasis Therapeutics Market?

North America was the largest region in the candidiasis therapeutics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the candidiasis therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Candidiasis Therapeutics Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the candidiasis therapeutics market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Candidiasis Therapeutics Market Include

1. Candidiasis Therapeutics Market Executive Summary

2. Candidiasis Therapeutics Market Segments

3. Candidiasis Therapeutics Market Size And Template Market Growth Rate

4. Key Candidiasis Therapeutics Market Trends

5. Major Candidiasis Therapeutics Market Drivers

……

25. Key Mergers And Acquisitions In The Candidiasis Therapeutics Market

26. Top Candidiasis Therapeutics Companies

27. Candidiasis Therapeutics Market Opportunities And Strategies

28. Candidiasis Therapeutics Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Digital Therapeutics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/digital-therapeutics-global-market-report

Leukemia Therapeutics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/leukemia-therapeutics-global-market-report

Liver Diseases Therapeutics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: